These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19607918)

  • 1. Burkitt lymphoma--a stalking horse for cancer research?
    Klein G
    Semin Cancer Biol; 2009 Dec; 19(6):347-50. PubMed ID: 19607918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Kelly G; Bell A; Rickinson A
    Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.
    Bornkamm GW
    Semin Cancer Biol; 2009 Dec; 19(6):351-65. PubMed ID: 19619654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes.
    Nagy N; Klein G; Klein E
    Semin Cancer Biol; 2009 Dec; 19(6):407-10. PubMed ID: 19874894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
    Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of EBV in microRNA dysregulation in Burkitt lymphoma.
    De Falco G; Antonicelli G; Onnis A; Lazzi S; Bellan C; Leoncini L
    Semin Cancer Biol; 2009 Dec; 19(6):401-6. PubMed ID: 19619656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-associated neoplasms: alternative pathogenetic pathways.
    Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Med Hypotheses; 2004; 62(3):387-91. PubMed ID: 14975509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
    J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma.
    Ruf IK; Rhyne PW; Yang H; Borza CM; Hutt-Fletcher LM; Cleveland JL; Sample JT
    Curr Top Microbiol Immunol; 2001; 258():153-60. PubMed ID: 11443860
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of LMP1 in immune control of EBV infection.
    Pai S; Khanna R
    Semin Cancer Biol; 2001 Dec; 11(6):455-60. PubMed ID: 11669607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epstein-Barr virus and Burkitt's lymphoma].
    Joab I
    Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity (a short review).
    Klein G
    Acta Microbiol Immunol Hung; 1996; 43(2-3):97-105. PubMed ID: 8876725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
    Allday MJ
    Semin Cancer Biol; 2009 Dec; 19(6):366-76. PubMed ID: 19635566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
    Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus and Burkitt lymphoma.
    Brady G; Macarthur GJ; Farrell PJ
    Postgrad Med J; 2008 Jul; 84(993):372-7. PubMed ID: 18716017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
    Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
    J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.